Cargando…

Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood–Retinal Barrier Integrity In Vitro

PURPOSE: Macular edema (ME) is a leading cause of visual loss in a range of retinal diseases and despite the use of antivascular endothelial growth factor (anti-VEGF) agents, its successful treatment remains a major clinical challenge. Based on the indirect clinical evidence that interleukin-6 (IL-6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mesquida, Marina, Drawnel, Faye, Lait, Philippa J., Copland, David A., Stimpson, Madeleine L., Llorenç, Victor, Sainz de la Maza, Maite, Adan, Alfredo, Widmer, Gabriella, Strassburger, Pamela, Fauser, Sascha, Dick, Andrew D., Lee, Richard W. J., Molins, Blanca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819001/ https://www.ncbi.nlm.nih.gov/pubmed/31667008 http://dx.doi.org/10.1167/tvst.8.5.32

Ejemplares similares

Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema
por: Matas, Jessica, et al.
Publicado: (2020)

Proinflammatory Cytokines and C-Reactive Protein in Uveitis Associated with Behçet's Disease
por: Mesquida, Marina, et al.
Publicado: (2014)

Re-programming immunosurveillance in persistent non-infectious ocular inflammation
por: Epps, Simon J., et al.
Publicado: (2018)

Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population
por: Rodrigues, Fabíola Brasil Barbosa, et al.
Publicado: (2023)

Interleukin 4 (IL-4) or IL-7 Prevents the Death of Resting T Cells: Stat6 Is Probably Not Required for the Effect of IL-4
por: Vella, Anthony, et al.
Publicado: (1997)

IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
por: Rose-John, Stefan
Publicado: (2012)

Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis
por: Matas, Jessica, et al.
Publicado: (2019)

IL6/IL6R genetic diversity and plasma IL6 levels in bipolar disorder: An Indo-French study
por: Sundaresh, Aparna, et al.
Publicado: (2019)

IL-6 Quotient (The Ratio of Cerebrospinal Fluid IL-6 to Serum IL-6) as a Biomarker of an Unruptured Intracranial Aneurysm
por: Kamińska, Joanna, et al.
Publicado: (2021)

Dissecting the IL‐6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R
por: Cupido, Arjen J., et al.
Publicado: (2022)

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6
Publicado: (1996)

Pathogenic roles of IL-6 and IL-6 blocking therapy on rheumatoid arthritis
por: Yoshizaki, K, et al.
Publicado: (2003)

Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
por: Wilson, Lori D, et al.
Publicado: (2012)

Assessment of Interleukins IL-4, IL-6, IL-8, IL-10 in Acute Urticaria
por: Papadopoulos, Jordan, et al.
Publicado: (2014)

The IL6 Gene Promoter SNP and Plasma IL-6 in Response to Diet Intervention
por: Rana, Brinda K., et al.
Publicado: (2017)

Special issue on Interleukin-6 (IL-6)
por: Rincon, Mercedes
Publicado: (2012)

Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts
por: Purohit, A, et al.
Publicado: (2003)

Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro
por: Flynn, Charlotte M., et al.
Publicado: (2020)

The nature of human IL-6
por: Puel, Anne, et al.
Publicado: (2019)

IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections.
por: Basso, Beatriz, et al.
Publicado: (2005)

Circulating IL-6, IL-10, and TNF-alpha and IL-10/IL-6 and IL-10/TNF-alpha ratio profiles of polyparasitized individuals in rural and urban areas of gabon
por: M’Bondoukwé, Noé Patrick, et al.
Publicado: (2022)

Unravelling the therapeutic potential of IL-33 for atrophic AMD
por: Clare, Alison J., et al.
Publicado: (2021)

IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis
por: Wang, Jianmei, et al.
Publicado: (2013)

A Potential Role of IL-6/IL-6R in the Development and Management of Colon Cancer
por: Turano, Mimmo, et al.
Publicado: (2021)

Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction
por: Aukrust, Pål, et al.
Publicado: (2021)

Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα/gp130 hexameric signaling complex formation
por: Chou, Chun-Chi, et al.
Publicado: (2022)

Interleukin‐6 signaling requires only few IL‐6 molecules: Relation to physiological concentrations of extracellular IL‐6
por: Hansen, Morten B.
Publicado: (2020)

Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema
por: Figueras-Roca, Marc, et al.
Publicado: (2017)

New tale on LianHuaQingWen: IL6R/IL6/IL6ST complex is a potential target for COVID-19 treatment
por: Tianyu, Zhao, et al.
Publicado: (2021)

Serum IL-1β, IL-2, and IL-6 in Insulin-Dependent Diabetic Children
por: Dogan, Yasar, et al.
Publicado: (2006)

Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity
por: Bester, Janette, et al.
Publicado: (2016)

Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer
por: Feng, Lanyun, et al.
Publicado: (2018)

Athletic humans and horses: Comparative analysis of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) expression in peripheral blood mononuclear cells in trained and untrained subjects at rest
por: Capomaccio, Stefano, et al.
Publicado: (2011)

Association Between Serum IL-6, IL-10, IL-12, and IL-23 Levels and Severity of Liver Cirrhosis
por: Rey, Imelda, et al.
Publicado: (2021)

Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients
por: Liu, Gang, et al.
Publicado: (2022)

Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months
por: Moll-Udina, Aina, et al.
Publicado: (2023)

Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies
por: Tawara, Ken, et al.
Publicado: (2011)

Classical Signaling and Trans-Signaling Pathways Stimulated by Megalobrama amblycephala IL-6 and IL-6R
por: Wang, Jixiu, et al.
Publicado: (2022)

Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19
por: Garbers, Christoph, et al.
Publicado: (2021)

IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity
por: Ng, Lisa F. P., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_afn9uapbrm9as98kquon1daqch